Share

December 2013; 3 (6) Five New Things

Neurorehabilitation

Five new things

A.M. Barrett, Mooyeon Oh-Park, Peii Chen, Nneka L. Ifejika
First published November 13, 2013, DOI: https://doi.org/10.1212/01.CPJ.0000437088.98407.fa
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1137

Share

Article Information

vol. 3 no. 6 484-492
DOI: 
https://doi.org/10.1212/01.CPJ.0000437088.98407.fa
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published November 13, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. A.M. Barrett, MD,
    2. Mooyeon Oh-Park, MD,
    3. Peii Chen, PhD and
    4. Nneka L. Ifejika, MD, MPH
  1. A.M. Barrett, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Kessler Foundation--for research activities

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Kessler Foundation (nonprofit public charity)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. Wrote three chapters for e-text WebMD/emedicine.com

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Pfizer/Eisai, O'Brien Technologies

    Research Support, Government Entities:

    1. NIH/NINDS and NIH/NICHD/NCMRR

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Kessler Foundation; the Healthcare Foundation of New Jersey; and the Wallerstein Foundation forGeriatric Improvement

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mooyeon Oh-Park, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Peii Chen, PhD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIDRR, H133G120203, role: co-I, 10/1/2012 - present2) NIH/NINDS,R01NS055808-01-A2, role: co-I, 09/01/2008 - 02/28/20133) NIH/NICHD, 1R03HD063177-01, role: PI, 09/10/2009 - 11/30/2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Nneka L. Ifejika, MD, MPH
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS Diversity Supplement to P50 NS 044227 University of Texas Specialized Program of Translational Research in Acute Stroke (SPOTRIAS).Role: Project Leader. Years 2010 to 2012.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Stroke Rehabilitation Research (AMB, MO-P, PC), Kessler Foundation, West Orange, NJ; Department of Physical Medicine and Rehabilitation (AMB, MO-P, PC), Rutgers–New Jersey Medical School, Newark, NJ; and Departments of Neurology and Physical Medicine and Rehabilitation (NLI), the University of Texas Medical School at Houston, Houston, TX.
  1. Correspondence to:
    abarrett{at}kesslerfoundation.org
View Full Text

Article usage

Article usage: November 2013 to June 2022

AbstractFullPdfSource
Nov 2013281320Highwire
Dec 20138042677Highwire
Jan 20144101229Highwire
Feb 2014202499129Highwire
Mar 2014125010Highwire
Apr 201415856Highwire
May 20147602Highwire
Jun 20148505Highwire
Jul 20144911Highwire
Aug 20144614Highwire
Sep 20146345Highwire
Oct 20147247Highwire
Nov 20144902Highwire
Dec 20146223Highwire
Jan 201517313Highwire
Jan 201501910pmc
Feb 20156013Highwire
Feb 201502811pmc
Mar 20154911Highwire
Mar 201502513pmc
Apr 20155101Highwire
Apr 201503171pmc
May 20152003Highwire
May 201502123pmc
Jun 20152201Highwire
Jun 201501711pmc
Jul 20154102Highwire
Jul 20150158pmc
Aug 20154112Highwire
Aug 201501312pmc
Sep 20153103Highwire
Sep 20150149pmc
Oct 20154211Highwire
Oct 201502416pmc
Nov 20152203Highwire
Nov 201501758pmc
Dec 20153221Highwire
Dec 20150115pmc
Jan 20163401Highwire
Jan 20160126pmc
Feb 20164502Highwire
Feb 201601210pmc
Mar 20164701Highwire
Mar 20160298pmc
Apr 20164525Highwire
Apr 201602470pmc
May 20165303Highwire
May 201601414pmc
Jun 20162222Highwire
Jun 20160113pmc
Jul 20162701Highwire
Jul 20160242pmc
Aug 20163100Highwire
Aug 2016052pmc
Sep 20163800Highwire
Sep 20160168pmc
Oct 20163100Highwire
Oct 2016065pmc
Nov 20163010Highwire
Nov 20160954pmc
Dec 20163100Highwire
Dec 20160107pmc
Jan 20174100Highwire
Jan 2017074pmc
Feb 20173300Highwire
Feb 20170117pmc
Mar 20173500Highwire
Mar 20170135pmc
Apr 20173600Highwire
Apr 2017432211pmc
May 20172001Highwire
May 201772016pmc
Jun 20171300Highwire
Jun 2017166pmc
Jul 20171000Highwire
Jul 2017277pmc
Aug 20173722Highwire
Aug 201731311pmc
Sep 20172011Highwire
Sep 201732223pmc
Oct 20172800Highwire
Oct 201732218pmc
Nov 20171400Highwire
Nov 2017422418pmc
Dec 20171400Highwire
Jan 20183401Highwire
Feb 20184510Highwire
Mar 20184212Highwire
Apr 20183700Highwire
Apr 2018588861pmc
May 20183321Highwire
Jun 20183600Highwire
Jun 201883437pmc
Jul 20183620Highwire
Aug 20183600Highwire
Aug 20187108117pmc
Sep 20183720Highwire
Oct 20182700Highwire
Nov 20182800Highwire
Dec 20183010Highwire
Jan 20193501Highwire
Feb 20192900Highwire
Mar 20193800Highwire
Apr 20193501Highwire
May 20194711Highwire
Jun 20192500Highwire
Jul 20192300Highwire
Aug 20191010Highwire
Sep 20192501Highwire
Oct 201915200Highwire
Nov 20193601Highwire
Dec 20198000Highwire
Jan 20203900Highwire
Feb 20202400Highwire
Mar 20202011Highwire
Apr 20201230Highwire
May 20204300Highwire
Jun 2020800Highwire
Jul 20201400Highwire
Aug 20201801Highwire
Sep 20202311Highwire
Oct 20203510Highwire
Nov 20203600Highwire
Dec 20204210Highwire
Jan 20212600Highwire
Feb 20212400Highwire
Mar 20212322Highwire
Apr 20212711Highwire
May 20215200Highwire
Jun 20212300Highwire
Jul 20212810Highwire
Aug 20212921Highwire
Sep 20211710Highwire
Oct 20215010Highwire
Nov 20214010Highwire
Dec 20213800Highwire
Jan 20223110Highwire
Feb 20222411Highwire
Mar 20225110Highwire
Apr 20225510Highwire
May 20224500Highwire
Jun 20221900Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me